Insider trade

Director sold ~$323K of COLL shares in the open market

Traded May 11, 2026 · Filed May 13, 2026

Why it stands out

A board member of Collegium Pharmaceutical sold $323K of Collegium Pharmaceutical shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$323,491

Shares × reported transaction price

Timing vs results

4 days after results of May 7, 2026, 87 days before results of Aug 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−1.2%	−0.7%	−0.5%
30 days	−1.8%	+0.9%	−2.7%
90 days	−26.2%	+3.3%	−29.5%

Past results only. Not a forecast.

The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.18 to $37.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.